Last reviewed · How we verify
Psilocybin therapy with Modafinil
At a glance
| Generic name | Psilocybin therapy with Modafinil |
|---|---|
| Also known as | 4-phosphoryloxy- N,N-dimethyltryptamine |
| Sponsor | Joshua Woolley, MD, PhD |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Psilocybin Therapy for Chronic Low Back Pain (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Psilocybin therapy with Modafinil CI brief — competitive landscape report
- Psilocybin therapy with Modafinil updates RSS · CI watch RSS
- Joshua Woolley, MD, PhD portfolio CI